Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757)
Copy Product Info
🥰Excellent
Synonyms:
Catalog No. T9901A-508 Copy Product Info
🥰Excellent
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is a humanized antibody arm derived from the half-life extended bispecific T-cell engager (BiTE) AMG-757. This product specifically targets Delta-like ligand 3 (DLL3), a Notch pathway ligand highly expressed in small-cell lung cancer (SCLC) and other neuroendocrine tumors but minimally expressed in normal tissues. It binds to the extracellular domain of DLL3 with picomolar (pM) affinity. In a bispecific format, it facilitates the redirection of T cells to DLL3-positive tumor cells, inducing T-cell activation and the release of cytotoxic granules to exert potent anti-tumor effects.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $722 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $1,980 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $3,260 | 2-4 weeks | 2-4 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Antibody Information
Storage & Solubility Information
| Description | Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is a humanized antibody arm derived from the half-life extended bispecific T-cell engager (BiTE) AMG-757. This product specifically targets Delta-like ligand 3 (DLL3), a Notch pathway ligand highly expressed in small-cell lung cancer (SCLC) and other neuroendocrine tumors but minimally expressed in normal tissues. It binds to the extracellular domain of DLL3 with picomolar (pM) affinity. In a bispecific format, it facilitates the redirection of T cells to DLL3-positive tumor cells, inducing T-cell activation and the release of cytotoxic granules to exert potent anti-tumor effects. |
| Targets & IC50 | DLL3 (human):0.64nM(Kd) |
| In vitro | The anti-DLL3 arm binds human DLL3 with high affinity (KD ≈ 0.64 nM). In T-cell and SCLC co-culture assays, the antibody redirects T cells, leading to robust activation (CD25/CD69 upregulation) and secretion of IFN-γ and TNF-α, which results in potent, dose-dependent lysis of DLL3-expressing tumor cells [1]. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | DLL3 |
| Isotype | IgG1 |
| Storage | Store at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) chemical structure | Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.